NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/10/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization13 mln
Float4.38 mln
Earnings Date11/18/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-1.87
Caution advised
Relative Strength
79
/ 100
Strongly outperforming
Debt / Equity
0.03
Debt-free
Pre-Tax Margin
-795%
Severely loss-making
ROE
-185
Deeply negative
Business Description
SeaStar Medical, founded in 2007 and based in Denver, Colorado, makes medical devices designed to protect vital organs from severe immune system overreactions. Its core technology works by calming overactive immune cells that would otherwise cause dangerous levels of inflammation throughout the body. The company currently offers a treatment for children suffering from kidney failure caused by sepsis, and is running clinical trials for a similar treatment in adults. SeaStar Medical is also exploring applications for its technology in other serious conditions affecting the heart and kidneys.
